Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Making It Personal
The comparisons are not mine; I cited my source. The Epoch Global Equity Shareholder Yield fund returned 26% last year, and a similar fund that Epoch runs for private clients has returned 16.5% annually for the last five years. Perhaps you can submit your contrarian reasoning to them. As for their philosophy and track record, I cannot argue with it.
Share
New Message
Please login to post a reply